Table 2.
Seroprevalence of BDV-specific circulating immune complexes (CIC) and antigen (Ag)
| In-patients | Blood donors-controls | p-value | Extinction values | |
|---|---|---|---|---|
| Total number, n | 106 | 98 | ||
| CIC positive, n (%) | 42 (39.6) | 22 (22.4) | 0.008 | |
| Men, n (%) | 16 (35.6) | 14 (20.9) | 0.086 | |
| Women, n (%) | 26 (42.6) | 8 (25.8) | 0.001 | |
| CIC negative, n (%) | 64 (60.4) | 76 (77.6) | 0.027 | ≤0.12 |
| CIC weak positive, n (%) | 15 (14.2) | 12 (12.2) | >0.12–0.15 | |
| CIC positive+, n (%) | 19 (17.9) | 8 (8.2) | >0.15–0.30 | |
| CIC positive++, n (%) | 8 (7.5) | 2 (2.0) | >0.30–0.60 | |
| Ag positive, n (%) | 7 (6.6) | 2 (2.0) | 0.113 | |
| Men, n (%) | 5 (11.1) | 2 (3.3) | 0.082 | |
| Women, n (%) | 2 (28.6) | 0 (0) | 0.308 | |
| Ag negative, n (%) | 99 (93.4) | 96 (98.0) | 0.255 | ≤0.12 |
| Ag weak positive, n (%) | 5 (4.7) | 1 (1.0) | >0.12–0.15 | |
| Ag positive+, n (%) | 2 (1.9) | 1 (1.0) | >0.15–0.30 |
Extinction values read at 405 nm microplate ELISA reader
p-values < 0.05 indicating statistical significance between groups. Significant differences are marked in bold